From Mad in Sweden: In a new report, the Swedish Medical Products Agency expresses concern about the sharp increase in ADHD diagnoses in Sweden. While the authority advises against expanding the right to prescribe central stimulant drugs, it emphasizes that the reasons behind the development are still insufficiently clarified – and need to be investigated to identify possible factors driving the diagnosis. The number of ADHD diagnoses in Sweden has increased sharply over the past 15 years. At the same time as the queues for specialist psychiatry are growing, the Swedish Medical Products Agency believes that society needs to pay more attention to why more and more people are being diagnosed – rather than just discussing access to drug treatment.
Read the full article in the original Swedish here. Please refer to this page for browser translation instructions.
